Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Silence Therapeutics Plc - American Depository Share
(NQ:
SLN
)
6.100
-1.030 (-14.45%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Silence Therapeutics Plc - American Depository Share
< Previous
1
2
3
4
5
6
Next >
Silence Therapeutics Provides SLN360 and SLN124 Clinical Program Updates
January 12, 2023
From
Silence Therapeutics
Via
Business Wire
Silence Therapeutics to Present at the 41st Annual J.P. Morgan Healthcare Conference
January 03, 2023
From
Silence Therapeutics
Via
Business Wire
Silence Therapeutics Reports Third Quarter 2022 Results
November 10, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics' Thalassemia Hopeful Shows Favorable Safety Profile In Early Stage Study
↗
September 29, 2022
Via
Benzinga
Why Coupa Software Shares Jumped Around 29%; Here Are 72 Biggest Movers From Wednesday
↗
November 25, 2022
Gainers Kalera Public Limited Company (NASDAQ: KAL) jumped 76.9% to close at $0.1610 on Wednesday after gaining 9% on Tuesday. Kalera recently posted a Q3 loss of $0.05 per share.
Via
Benzinga
Silence Therapeutics to Present at Jefferies London Healthcare Conference
November 09, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Presents New Analysis from SLN360 Phase 1 Single Dose Study in High Lipoprotein(a) at the American Heart Association (AHA) 2022 Annual Meeting
November 05, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces Preliminary Single Dose Results from SLN124 Phase 1 Study in Patients with Thalassemia
September 29, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Participate in Fireside Chat at Chardan Genetic Medicines Conference
September 27, 2022
From
Silence Therapeutics plc
Via
Business Wire
Important Biotech Catalysts For September 8, 2022 - End Of The Day Summary
↗
September 08, 2022
Via
Benzinga
Silence Therapeutics Gets FDA Fast Track Status For Blood Cancer Candidate
↗
September 08, 2022
Silence Therapeutics (NASDAQ: SLN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation to its lead candidate SLN124 for the treatment of polycythemia vera...
Via
Benzinga
Silence Therapeutics to Participate in September Investment Conferences
September 08, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces FDA Fast Track Designation for SLN124, a Novel Investigational siRNA Therapy for the Treatment of Polycythemia Vera
September 08, 2022
From
Silence Therapeutics plc
Via
Business Wire
Workday, Electronic Arts, Ulta Beauty And Some Other Big Stocks Moving Higher On Friday
↗
August 26, 2022
Micro Focus International plc (NYSE: MFGP) shares jumped 95.4% to $6.11 after the company reached an agreement with OpenText to be acquired for $6 billion.
Via
Benzinga
This Biotechnology Stock Tumbled 37%; Here Are 70 Biggest Movers From Yesterday
↗
August 19, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares climbed 135.9% to close at $2.17 on Thursday.
Via
Benzinga
Why Plus Therapeutics Is Trading Higher By Over 50%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
↗
August 18, 2022
Gainers Bright Minds Biosciences Inc. (NASDAQ: DRUG) shares jumped 297% to $3.66.
Via
Benzinga
Silence Therapeutics Announces Pricing of Underwritten Offering
August 11, 2022
From
Silence Therapeutics plc
Via
Business Wire
76 Biggest Movers From Yesterday: Ocean Bio-Chem, Athira Pharma And More
↗
June 23, 2022
Gainers Ocean Bio-Chem, Inc. (NASDAQ: OBCI) shares climbed 117.2% to close at $12.86 on Wednesday after the company announced it will be acquired by OneWater Marine for $13.08 per share in cash.
Via
Benzinga
Silence Therapeutics to Present at Jefferies Healthcare Conference
June 02, 2022
From
Silence Therapeutics plc
Via
Business Wire
88 Biggest Movers From Yesterday
↗
May 26, 2022
Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...
Via
Benzinga
Silence Therapeutics to Participate in Fireside Chat at H.C. Wainwright Global Investment Conference
May 18, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Reports First Quarter 2022 Results
May 16, 2022
From
Silence Therapeutics plc
Via
Business Wire
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
May 10, 2022
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
April 28, 2022
Via
Benzinga
74 Biggest Movers From Yesterday
↗
April 29, 2022
Gainers T Stamp Inc. (NASDAQ: IDAI) shares surged 123.8% to close at $4.70 on Thursday. Trust Stamp reported the launch of its Biometric Multi-Factor Authentication (Biometric...
Via
Benzinga
38 Stocks Moving In Wednesday's Mid-Day Session
↗
April 27, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) gained 154% to $4.3550 after the company announced it has signed a 10-year contract with Hot Oil Transport with a potential value of...
Via
Benzinga
61 Biggest Movers From Yesterday
↗
April 28, 2022
Gainers Vivakor, Inc. (NASDAQ: VIVK) shares jumped 113.5% to close at $3.65 on Wednesday after the company announced it has signed a 10-year contract with Hot Oil Transport with...
Via
Benzinga
Silence Therapeutics Achieves $2 Million Research Milestone in Hansoh Pharma Collaboration
April 25, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics to Present at 21st Annual Needham Virtual Healthcare Conference
April 06, 2022
From
Silence Therapeutics plc
Via
Business Wire
Silence Therapeutics Announces Publication in the Journal of the American Medical Association Highlighting Results From SLN360 Phase 1 Study in Healthy Adults With High Lipoprotein(a)
April 03, 2022
From
Silence Therapeutics plc
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
